IRF6 Antibody (N-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP1406a
Background:
IRF6 is a member of the interferon regulatory transcription factor (IRF) family. Family members share a highly-conserved N-terminal helix-turn-helix DNA-binding domain and a less conserved C-terminal protein-binding domain. Mutations in this gene can cause van der Woude syndrome and popliteal pterygium syndrome. This protein is involved in palate formation.
Other Names:
Interferon regulatory factor 6, IRF-6, IRF6
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP1406a was selected from the N-term region of human IRF6. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: IRF6
Gene ID: 3664
Primary Accession: O14896
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
IRF6 is a member of the interferon regulatory transcription factor (IRF) family. Family members share a highly-conserved N-terminal helix-turn-helix DNA-binding domain and a less conserved C-terminal protein-binding domain. Mutations in this gene can cause van der Woude syndrome and popliteal pterygium syndrome. This protein is involved in palate formation.
Other Names:
Interferon regulatory factor 6, IRF-6, IRF6
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP1406a was selected from the N-term region of human IRF6. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: IRF6
Gene ID: 3664
Primary Accession: O14896
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review